122 related articles for article (PubMed ID: 12215291)
41. Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA.
Koga S; Kondo Y; Komata T; Kondo S
Gene Ther; 2001 Apr; 8(8):654-8. PubMed ID: 11320413
[TBL] [Abstract][Full Text] [Related]
42. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
43. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
44. Amplification of telomerase reverse transcriptase gene in human mammary epithelial cells with limiting telomerase RNA expression levels.
Cao Y; Huschtscha LI; Nouwens AS; Pickett HA; Neumann AA; Chang AC; Toouli CD; Bryan TM; Reddel RR
Cancer Res; 2008 May; 68(9):3115-23. PubMed ID: 18451136
[TBL] [Abstract][Full Text] [Related]
45. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
46. Human hepatoma cell telomerase activity inhibition and cell cycle modulation by its RNA component antisense oligodeoxyribonucleotides.
Zhang RG; Wang XW; Yuan JH; Xie H
Acta Pharmacol Sin; 2000 Aug; 21(8):742-6. PubMed ID: 11501185
[TBL] [Abstract][Full Text] [Related]
47. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B
Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713
[TBL] [Abstract][Full Text] [Related]
48. [The study on the correlation between telomerase and histopathologic features of retinoblastoma].
Ren RJ; Li B; Sun XL; Zheng BH; Li LQ; Chen CX
Zhonghua Yan Ke Za Zhi; 2004 Apr; 40(4):234-8. PubMed ID: 15268829
[TBL] [Abstract][Full Text] [Related]
49. Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease overexpress the telomerase RNA template (hTR).
Heine B; Hummel M; Demel G; Stein H
J Pathol; 1999 Jun; 188(2):139-45. PubMed ID: 10398156
[TBL] [Abstract][Full Text] [Related]
50. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
Novakovic S; Hocevar M; Zgajnar J; Besic N; Stegel V
Oncol Rep; 2004 Jan; 11(1):245-52. PubMed ID: 14654933
[TBL] [Abstract][Full Text] [Related]
51. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
[TBL] [Abstract][Full Text] [Related]
52. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
Wadhwa R; Takano S; Taira K; Kaul SC
J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818
[TBL] [Abstract][Full Text] [Related]
53. [Study on the expression of telomerase RNA in leukocyte].
Jin L; Zhang H; Dai F; An L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Mar; 20(1):76-8. PubMed ID: 12744168
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of human telomerase reverse transcriptase in hep-2 cells using short hairpin RNA expression vectors.
Chen SM; Tao ZZ; Hua QQ; Liu D; Chi HM; Cai Q
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):200-5. PubMed ID: 16490880
[TBL] [Abstract][Full Text] [Related]
55. Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells.
Duan J; Chen Z; Liu P; Zhang Z; Tong T
Int J Oncol; 2004 Jun; 24(6):1597-605. PubMed ID: 15138605
[TBL] [Abstract][Full Text] [Related]
56. Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma.
Zhou JH; Zhang HM; Chen Q; Han DD; Pei F; Zhang LS; Yang DT
World J Gastroenterol; 2003 Aug; 9(8):1808-14. PubMed ID: 12918126
[TBL] [Abstract][Full Text] [Related]
57. [Expression of osm gene driven by hTERT gene promoter inhibits cancer cells proliferation in vitro].
Yang YJ; Zheng XF; Zhu J; Lu X; Luo Y; Sun ZX
Ai Zheng; 2003 Jun; 22(6):575-8. PubMed ID: 12948403
[TBL] [Abstract][Full Text] [Related]
58. [A DNA vector-based RNAi technology to inhibit the activity of the telomerase of cell line HCCLM3].
Lu XD; Qin WX; Pan DN; Li JJ; Wan DF; Wen CJ; Li CJ; Gu JR; Yang SL
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1381-5. PubMed ID: 15387948
[TBL] [Abstract][Full Text] [Related]
59. Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy.
Ji XM; Xie CH; Fang MH; Zhou FX; Zhang WJ; Zhang MS; Zhou YF
Acta Pharmacol Sin; 2006 Sep; 27(9):1185-91. PubMed ID: 16923339
[TBL] [Abstract][Full Text] [Related]
60. GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells.
Nagai N; Oshita T; Mukai K; Shiroyama Y; Shigemasa K; Ohama K
Int J Mol Med; 2002 Nov; 10(5):593-7. PubMed ID: 12373298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]